Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Lee

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Clinical Kidney Journal|March 24, 2025
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseasesJeffery C H Chan, Eugene Yu-Hin Chan, Samuel M S Cheng, et al.
Kidney International Reports|November 29, 2023
Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney DiseasesDaniel Leung, Eugene Yu-Hin Chan, Xiaofeng Mu, et al.
Kidney International Reports|October 18, 2023
Humoral and Cellular Immunogenicity and Safety of 3-Dose Inactivated COVID-19 Vaccine in Young Children Less Than 5 Years With Kidney DiseasesEugene Yu-Hin Chan, Daniel Leung, Samuel M S Cheng, et al.
Signal Transduction and Targeted Therapy|December 14, 2022
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescentsXiaofeng Mu, Carolyn A Cohen, Daniel Leung, et al.
Frontiers in Immunology|October 7, 2022
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunityDaniel Leung, Xiaofeng Mu, Jaime S Rosa Duque, et al.
World Journal of Pediatrics : WJP|December 12, 2023
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescentsJaime S Rosa Duque, Samuel M S Cheng, Carolyn A Cohen, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Clinical Kidney Journal|March 24, 2025
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseasesJeffery C H Chan, Eugene Yu-Hin Chan, Samuel M S Cheng, et al.
Kidney International Reports|November 29, 2023
Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney DiseasesDaniel Leung, Eugene Yu-Hin Chan, Xiaofeng Mu, et al.
Kidney International Reports|October 18, 2023
Humoral and Cellular Immunogenicity and Safety of 3-Dose Inactivated COVID-19 Vaccine in Young Children Less Than 5 Years With Kidney DiseasesEugene Yu-Hin Chan, Daniel Leung, Samuel M S Cheng, et al.
Signal Transduction and Targeted Therapy|December 14, 2022
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescentsXiaofeng Mu, Carolyn A Cohen, Daniel Leung, et al.
Frontiers in Immunology|October 7, 2022
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunityDaniel Leung, Xiaofeng Mu, Jaime S Rosa Duque, et al.
World Journal of Pediatrics : WJP|December 12, 2023
Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescentsJaime S Rosa Duque, Samuel M S Cheng, Carolyn A Cohen, et al.
Pageof 9